Form 4: Novavax Director David M. Mott Reports Stock Transactions
SEC Form 4
Director David M. Mott reports acquisition and disposal of Novavax stock and derivative securities on June 12, 2024.
Summary
- On June 12, 2024, David M. Mott, a director of Novavax Inc., reported transactions involving the company's stock.
- Mott disposed of 6,670 shares of Common Stock.
- Mott also reported transactions involving derivative securities, including Restricted Stock Units and Stock Options.
- These transactions were reported on Form 4, filed with the Securities and Exchange Commission.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions by a company director. It doesn't inherently convey positive or negative sentiment about the company's prospects.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities. It doesn't necessarily reflect the company's overall performance or future prospects but offers insights into individual executive's perspectives.
Stakeholder Impact
- The transactions may be of interest to shareholders as they provide insight into the actions of a company director.
Key Dates
| Date | Description |
|---|---|
| 06/12/2024 | Date of earliest transaction: disposal of common stock and acquisition of stock options and restricted stock units. |
| 06/12/2025 | Date from which stock options and restricted stock units are exercisable. |
| 06/12/2033 | Expiration date for restricted stock units. |
| 06/12/2034 | Expiration date for stock options. |
| 06/14/2024 | Date of signature by Attorney-in-Fact. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.